Prognostic impact of CD109 expression in myxofibrosarcoma

MLA

Satoshi Nagoya, et al. “Prognostic Impact of CD109 Expression in Myxofibrosarcoma.” Journal of Surgical Oncology, vol. 111, May 2015, pp. 975–79. EBSCOhost, https://doi.org/10.1002/jso.23934.

APA

Satoshi Nagoya, Tamotsu Soma, Tomoko Sonoda, Mikito Sasaki, Makoto Emori, Mitsunori Kaya, Kenji Murata, Toshihiko Yamashita, Tadashi Hasegawa, Shintaro Sugita, Noriyuki Sato, Takuro Wada, & Tomohide Tsukahara. (2015). Prognostic impact of CD109 expression in myxofibrosarcoma. Journal of Surgical Oncology, 111, 975–979. https://doi.org/10.1002/jso.23934

Chicago

Satoshi Nagoya, Tamotsu Soma, Tomoko Sonoda, Mikito Sasaki, Makoto Emori, Mitsunori Kaya, Kenji Murata, et al. 2015. “Prognostic Impact of CD109 Expression in Myxofibrosarcoma.” Journal of Surgical Oncology 111 (May): 975–79. doi:10.1002/jso.23934.